These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2846368)

  • 1. Haemodynamic and haematologic alterations with protamine reversal of anticoagulation: comparison of standard heparin and a low molecular weight heparin fragment.
    Lindblad B; Borgström A; Wakefield TW; Whitehouse WM; Stanley JC
    Eur J Vasc Surg; 1987 Jun; 1(3):181-5. PubMed ID: 2846368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective and less toxic reversal of low-molecular weight heparin anticoagulation by a designer variant of protamine.
    Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Schmidt R; Tejwani S; Stanley JC
    J Vasc Surg; 1995 May; 21(5):839-49; discussion 849-50. PubMed ID: 7769743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
    Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
    Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation.
    Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Tejwani S; Hulin MS; Stanley JC
    J Surg Res; 1996 Jun; 63(1):280-6. PubMed ID: 8661211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of complement-mediated events after protamine reversal of heparin anticoagulation.
    Wakefield TW; Kirsh MM; Till GO; Brothers TE; Hantler CB; Stanley JC
    J Surg Res; 1991 Jul; 51(1):72-6. PubMed ID: 2067362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressed cardiovascular function and altered platelet kinetics following protamine sulfate reversal of heparin activity.
    Wakefield TW; Whitehouse WM; Stanley JC
    J Vasc Surg; 1984 Mar; 1(2):346-55. PubMed ID: 6481883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
    Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC
    Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal.
    DeLucia A; Wakefield TW; Andrews PC; Nichol BJ; Kadell AM; Wrobleski SK; Downing LJ; Stanley JC
    J Vasc Surg; 1993 Jul; 18(1):49-58; discussion 58-60. PubMed ID: 8326659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prostacyclin and adverse hemodynamic responses to protamine sulfate in an experimental canine model.
    Wakefield TW; Wrobleski SK; Wirthlin DJ; Wang TW; Stanley JC
    J Surg Res; 1991 May; 50(5):449-56. PubMed ID: 2038184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of low-molecular-weight heparin anticoagulation by synthetic protamine analogues.
    Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Fazzalari A; Nichol BJ; Vanderkooi T; Stanley JC
    J Surg Res; 1994 Jun; 56(6):586-93. PubMed ID: 8015315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide inhibition attenuates systemic hypotension produced by protamine.
    Raikar GV; Hisamochi K; Raikar BL; Schaff HV
    J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1240-6; discussion 1246-7. PubMed ID: 8642826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant effects of protamine sulfate in a canine model.
    Kresowik TF; Wakefield TW; Fessler RD; Stanley JC
    J Surg Res; 1988 Jul; 45(1):8-14. PubMed ID: 3392995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protamine pretreatment attenuation of hemodynamic and hematologic effects of heparin-protamine interaction. A prospective randomized study in human beings undergoing aortic reconstructive surgery.
    Wakefield TW; Hantler CB; Lindblad B; Whitehouse WM; Stanley JC
    J Vasc Surg; 1986 Jun; 3(6):885-9. PubMed ID: 3712636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protamine reversal of anticoagulation achieved with a low molecular weight heparin. The effects on eicosanoids, clotting and complement factors.
    Lindblad B; Borgström A; Wakefield TW; Whitehouse WM; Stanley JC
    Thromb Res; 1987 Oct; 48(1):31-40. PubMed ID: 2827339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated administration of protamine does not attenuate circulatory changes caused by protamine reversal of heparin in dogs.
    Mizutani T; Takahashi S; Kihara S; Toyooka H
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):346-51. PubMed ID: 11426367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement depletion and persistent hemodynamic-hematologic responses in protamine-heparin reactions.
    Wakefield TW; Till GO; Lindblad B; Saenz N; Stanley JC
    J Surg Res; 1988 Sep; 45(3):320-6. PubMed ID: 3411956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The haemodynamic effects of intraaortic versus intravenous administration of protamine for reversal of heparin in man.
    Milne B; Rogers K; Cervenko F; Salerno T
    Can Anaesth Soc J; 1983 Jul; 30(4):347-51. PubMed ID: 6871776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased oxygen consumption as a toxic manifestation of protamine sulfate reversal of heparin anticoagulation.
    Wakefield TW; Ucros I; Kresowik TF; Hinshaw DB; Stanley JC
    J Vasc Surg; 1989 Jun; 9(6):772-7. PubMed ID: 2724464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep.
    Montalescot G; Zapol WM; Carvalho A; Robinson DR; Torres A; Lowenstein E
    Circulation; 1990 Nov; 82(5):1754-64. PubMed ID: 2171807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of depressed oxygen consumption accompanying in vivo protamine sulphate-heparin interactions by the prostacyclin analogue, iloprost.
    Wakefield TW; Wrobleski SK; Stanley JC
    Eur J Vasc Surg; 1990 Feb; 4(1):25-31. PubMed ID: 1691112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.